Abstract

Is There Sufficient Evidence to Support the Use of Intravenous N-acetylcysteine for the Prevention of Contrast Induced Nephropathy?

Highlights

  • ; Fax: 3522655606; Email: Abstract We discuss the safety of efficacy of using intravenous N-acetylcysteine for the prevention of contrast induced nephropathy

  • Is there sufficient evidence to support the use of intravenous N-acetylcysteine for the prevention of contrast induced nephropathy? Basically, the answer is a simple yes and no, depending on the clinical situation, the patient and the radiological study or procedure in question

  • There is no single consensus for contrast-induced nephropathy, many studies define contrast induced nephropathy (CIN) as a 25% relative or 0.5 mL/min increase in serum creatinine clearance (SCr)

Read more

Summary

Mini Review

Is There Sufficient Evidence to Support the Use of Intravenous N-acetylcysteine for the Prevention of Contrast Induced Nephropathy?. ; Fax: 3522655606; Email: Abstract We discuss the safety of efficacy of using intravenous N-acetylcysteine for the prevention of contrast induced nephropathy. We discuss the relevant literature and provide evidenced-based recommendation

Introduction
Discussion
Conclusion and Summary of recommendations
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.